Octapharma
Octapharma AG, founded in 1983, is a family-owned pharmaceutical company, and bills itself as "one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines."
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Cutaquig | Immune globulin subcutaneous (human) | 2018-12-12 | — | |
| N/a | Albumin (human) | 2006-10-17 | — | |
| Nuwiq | Simoctocog alfa, Antihemophilic factor (recombinant) | 2014-07-22 | ||
| Octagam | Immune globulin intravenous (human) | 2004-05-21 | — | |
| Panzyga | Immune globulin intravenous (human) | 2018-08-02 | — | |
| Vihuma | Simoctocog alfa | 2017-02-13 | ||
| Wilate | Coagulation factor viii complex (human), Von willebrand factor | 2010-12-20 | ||
| Fibryga | Fibrinogen (human) | 2017-06-07 | — |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use